izpis_h1_title_alt

Retrospektivna analiza farmakoterapije akutno dializiranih bolnikov v Splošni bolnišnici "dr. Franca Derganca" Nova Gorica
ID Stopar, Veronika (Author), ID Vovk, Tomaž (Mentor) More about this mentor... This link opens in a new window, ID Kenda, Sara (Comentor)

.pdfPDF - Presentation file, Download (2,08 MB)
MD5: 4E2864A9A37ED03E953E5B4F3C79B40E

Abstract
Ledvice so ključni organ, preko katerega se izločajo tako endogene kot eksogene odpadne snovi. Odpoved delovanja ledvic vodi v kopičenje le-teh, mnoge med njimi pa lahko odstranimo s pomočjo različnih dializnih metod. Namen magistrske naloge je bil pregled farmakoterapije bolnikov, ki so v letu 2018 zaradi akutne odpovedi ledvic potrebovali dializno zdravljenje v Splošni bolnišnici dr. Franca Derganca Nova Gorica. Osredotočili smo se na ustreznost odmerjanja protimikrobnih zdravil glede na različna priporočila, in sicer The Renal Drug Handbook (TRDH) in NebraskaMed (NM) ter povzetke glavnih značilnosti (SmPC) posameznih protimikrobnih zdravil. V raziskavo je bilo vključenih 40 bolnikov. Ugotovili smo, da so bila protimikrobna zdravila predpisana na način, ki je bil najbolj skladen s priporočili TRDH (67,78 %), temu so sledili predpisi iz SmPC (62,06 %), še najmanj pa so jih predpisovali glede na priporočila NM (59,21 %). Za vsako predpisano protimikrobno zdravilo smo pri vsakem obravnavanem pacientu preverili ustreznost odmerka, intervala in časa odmerjanja, glede na čas dialize ter učinkovitost zdravljenja. Bolniki so protimikrobna zdravila prejemali v 76,19 % primerov v ustreznem odmerku, veliko manj pa v ustreznem intervalu (58,44 %), v 68,57 % primerov so bila ta zdravila ustrezno odmerjena glede na čas izvedbe dialize. Spearmanov koeficient korelacije je za povezanost med ustreznostjo odmerka in učinkovitostjo znašal 0,236, za ustreznost odmernega intervala in učinkovitost 0,402, za ustreznost odmerjanja glede na čas HD in učinkovitost pa 0,258. Korelacija med spremenljivkami je bila šibka oz. zmerna. Značilna je bila le za učinkovitost in odmerni interval glede na izračunano stopnjo značilnosti (p = 0,036). Preverili smo tudi potencialne interakcije med zdravili, ki pa se pri bolnikih niso klinično izrazile. Glavna težava pri vrednotenju ustreznosti farmakoterapije je bila odsotnost podatka o telesni masi večine bolnikov (75 %), na podlagi katere bi lahko izračunali očistek kreatinina, ki je osnova za določitev odmerjanja zdravil pri ledvični odpovedi. Odmerjanje zdravil glede na oceno ledvične funkcije po enačbi »The Chronic Kidney Disease Epidemiology Collaboration«, ki se rutinsko uporablja v bolnišničnem okolju, ni ustrezno pri tistih bolnikih , ki v telesni masi zelo odstopajo od povprečja. V SB dr. Franca Derganca se zaenkrat izvaja terapevtsko spremljanje koncentracije (TDM) le za vankomicin in gentamicin. Pri odmerjanju zdravil pa je klinični farmacevt sodeloval le pri enem pacientu. Za boljšo obravnavo bi bilo smiselno razširiti uporabo TDM tudi na druga zdravila, kjer je to mogoče, ter glede na pozitivne izsledke številnih študij v zdravstveni tim redno vključiti tudi kliničnega farmacevta.

Language:Slovenian
Keywords:dializna farmakoterapija Nova Gorica 2018
Work type:Master's thesis/paper
Organization:FFA - Faculty of Pharmacy
Year:2022
PID:20.500.12556/RUL-137860 This link opens in a new window
Publication date in RUL:04.07.2022
Views:702
Downloads:96
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Retrospective analysis of acute dialysis patients' pharmacotherapy in "dr. Franc Derganc" Nova Gorica General Hospital
Abstract:
Kidneys play crucial role in eliminating certain endogenous and exogenous substances. Kidney failure leads to accumulation of those substances, which can be eliminated via different dialysis methods. The purpose of our research was analysis of pharmacotherapy of patients undergoing acute renal replacement therapy in General Hospital dr. Franc Derganc Nova Gorica in 2018. We focused on adequacy of antimicrobial agents dosing according to different guidelines, such as The Renal Drug Handbook (TRDH) and NebraskaMed (NM) and Summary of product characteristics (SmPCs) of different medicines. Our study included 40 patients. Antimicrobial agents were prescribed in accordance with TRDH guidelines in 67,78 %, in 62,06 % with SmPCs and in 59,21 % in accordance with NM guidelines. For each antimicrobial medication prescribed we evaluated adequacy of dose, interval of dosing, time of dosing depending on time of dialysis and treatment effectiveness. In 76,19 % patients received adequate dose, in 58,44 % the dosing interval was adequate, in 68,57 % of cases the time of antimicrobial agent dosing was adequate. Spearman's coefficient for correlation between adequacy of dose and effectiveness was 0,236, for adequacy of dosing interval and effectiveness 0,402 and for time of dosing depending on time of dialysis and effectiveness was 0,258. Correlation between effectiveness and adequacy of dosing was weak to mild, according to calculated significance level only correlation between dosing interval and effectivness was significant (p=0,036). We evaluated the potential interactions between medicines prescribed, but none of them was clinically observed. Our main issue in evaluating medication dosing was absence of patient's body weight information in 75 % of cases, which would enable us to determine crucial parameter for evaluation of proper medicine dosing - creatinine clearance. Prescribing medicine dose according to »The Chronic Kidney Disease Collaboration« equation, which is used routinely in hospital environment, is not appropriate for patients with very high or very low body wight. Therapeutic drug monitoring in General Hospital dr. Franc Derganc Nova Gorica is available only for vancomycin and gentamicin. Clinical pharmacist participated in treatment of only one patient. To improve the quality of pharmacotherapy treatment in patients undergoing renal replacement therapy it would be worth considering the use of therapeutic drug monitoring also in other antimicrobial agents, when possible. Clinical pharmacist should be considered regular healthcare team member according to positive results of studies, which evaluated the clinical pharmacist's role in pharmacotherapy treatment of patients undergoing dialysis.

Keywords:dialysis pharmacotherapy Nova Gorica 2018

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back